These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10577351)

  • 21. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
    Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ
    Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.
    Munshi MH; Sack DA; Haider K; Ahmed ZU; Rahaman MM; Morshed MG
    Lancet; 1987 Aug; 2(8556):419-21. PubMed ID: 2887725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of quinolone-resistant Shigella dysenteriae type 1 in Canada.
    Can Commun Dis Rep; 2005 Oct; 31(19):193-7. PubMed ID: 16200675
    [No Abstract]   [Full Text] [Related]  

  • 26. Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals.
    Heurtin-Le Corre C; Donnio PY; Perrin M; Travert MF; Avril JL
    J Clin Microbiol; 1999 Jan; 37(1):266-9. PubMed ID: 9854111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.
    Gensberg K; Jin YF; Piddock LJ
    FEMS Microbiol Lett; 1995 Oct; 132(1-2):57-60. PubMed ID: 7590165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.
    Hakanen A; Kotilainen P; Jalava J; Siitonen A; Huovinen P
    J Clin Microbiol; 1999 Nov; 37(11):3572-7. PubMed ID: 10523554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
    Martínez-Martínez L; Fernández F; Perea EJ
    J Antimicrob Chemother; 1999 Feb; 43(2):277-9. PubMed ID: 11252335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serogroup prevalence of Shigellae in Bombay.
    Sonawala M; Saraswathi K; Deodhar LP
    J Postgrad Med; 1995; 41(4):104-6. PubMed ID: 10707731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.
    Malorny B; Schroeter A; Helmuth R
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2278-82. PubMed ID: 10471579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shigella infections among children in Andaman--an archipelago of tropical islands in Bay of Bengal.
    Ghosh AR; Sehgal SC
    Epidemiol Infect; 1998 Aug; 121(1):43-8. PubMed ID: 9747754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece.
    Chatzipanagiotou S; Papavasiliou E; Malamou-Lada E
    Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):566-8. PubMed ID: 8404924
    [No Abstract]   [Full Text] [Related]  

  • 34. An outbreak of bacillary dysentery caused by quinolone-resistant Shigella dysenteriae type 1 in a northeastern state of India.
    Niyogi SK; Sarkar K; Lalmalsawma P; Pallai N; Bhattacharya SK
    J Health Popul Nutr; 2004 Mar; 22(1):97. PubMed ID: 15190817
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High rate of resistance to nalidixic acid in Salmonella enterica: its role as a marker of resistance to fluoroquinolones.
    Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
    Clin Microbiol Infect; 2000 May; 6(5):273-6. PubMed ID: 11168127
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
    J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance.
    Bogaerts J; Verhaegen J; Munyabikali JP; Mukantabana B; Lemmens P; Vandeven J; Vandepitte J
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):165-71. PubMed ID: 9327243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.